https://tmxmatrix.com/company/IPA/financings
I am really looking forward to the next few weeks / months. Thanks for the article you shared. IPA has the know how and combined with AI it just makes them that much better. As well combination of the all the animal mAB Therapeutics just speeds up the game that much faster.
I am an optimistic, believe in IPA. This is their time to come to the plate and hit the home run.
Recent IPA News
- Une percée commerciale de 20 milliards de dollars : l'IPA est pionnière dans le développement d'anticorps à fort impact pour les thérapies anticancéreuses ADC de nouvelle génération • Business Wire • 11/14/2024 08:13:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2024 02:17:08 PM
- $20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies • Business Wire • 11/13/2024 02:00:00 PM
- ImmunoPrecise annonce son TECHDAY, un événement dédié à l'innovation de pointe en matière d'IA et de produits biologiques • Business Wire • 11/05/2024 06:53:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/04/2024 01:54:49 PM
- ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation • Business Wire • 11/04/2024 01:01:00 PM
- ImmunoPrecise soutient la recherche antivieillissement dans le cadre d'une étude de la Mayo Clinic et s'apprête à entrer dans un marché de 81 milliards de dollars avec une technologie d'IA • Business Wire • 10/29/2024 01:59:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/28/2024 11:36:23 AM
- ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology • Business Wire • 10/28/2024 11:30:00 AM
- ImmunoPrecise Antibodies participera à l'AI Driven Drug Discovery Summit USA 2024 • Business Wire • 10/23/2024 10:11:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/21/2024 01:08:58 PM
- ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 • Business Wire • 10/21/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/11/2024 07:25:08 PM
- ImmunoPrecise Antibodies célèbre le prix Nobel de chimie et les avancées dans la conception de protéines optimisée par l'IA • Business Wire • 10/10/2024 11:50:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/10/2024 01:39:39 PM
- ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design • Business Wire • 10/10/2024 12:10:00 PM
- Une filiale d'ImmunoPrecise signe un accord de transfert de matériel avec Biotheus • Business Wire • 10/02/2024 06:06:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/02/2024 12:02:26 PM
- ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus • Business Wire • 10/02/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/26/2024 01:13:32 PM
- ImmunoPrecise Antibodies promeut l'innovation thérapeutique avec des avancées révolutionnaires sur les anticorps de lapin • Business Wire • 09/26/2024 01:00:00 PM
- ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments • Business Wire • 09/26/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 06:40:14 PM
- ImmunoPrecise Antibodies (IPA) publie ses résultats financiers et les faits saillants de ses activités du premier trimestre de l’exercice 2025 • Business Wire • 09/17/2024 02:13:00 AM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 09/16/2024 08:01:33 PM
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM